GlaxoSmithKline
GSK
#209
Rank
โ‚น8.778 T
Marketcap
โ‚น4,349
Share price
-0.33%
Change (1 day)
53.61%
Change (1 year)

Revenue for GlaxoSmithKline (GSK)

Revenue in 2025 (TTM): โ‚น3.664 Trillion

According to GlaxoSmithKline's latest financial reports the company's current revenue (TTM ) is โ‚น3.804 Trillion. In 2024 the company made a revenue of โ‚น3.446 Trillion an increase over the revenue in the year 2023 that were of โ‚น3.155 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GlaxoSmithKline from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น3.664 T6.31%
2024 โ‚น3.446 T9.24%
2023 โ‚น3.155 T7.37%
2022 โ‚น2.938 T-1.51%
2021 โ‚น2.983 T-6.87%
2020 โ‚น3.203 T4.25%
2019 โ‚น3.073 T7.85%
2018 โ‚น2.849 T12.65%
2017 โ‚น2.529 T1.17%
2016 โ‚น2.500 T4.06%
2015 โ‚น2.402 T0.68%
2014 โ‚น2.386 T-7.64%
2013 โ‚น2.583 T11.63%
2012 โ‚น2.314 T1.1%
2011 โ‚น2.289 T16.87%
2010 โ‚น1.959 T-5.65%
2009 โ‚น2.076 T-1.03%
2008 โ‚น2.098 T17.65%
2007 โ‚น1.783 T-6.11%
2006 โ‚น1.899 T9.43%
2005 โ‚น1.735 T6.38%
2004 โ‚น1.631 T0.18%
2003 โ‚น1.628 T4.5%
2002 โ‚น1.558 T9.34%
2001 โ‚น1.425 T11.54%
2000 โ‚น1.277 T109.97%
1999 โ‚น608.60 B6.88%
1998 โ‚น569.40 B11.77%
1997 โ‚น509.46 B-12.24%
1996 โ‚น580.55 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AstraZeneca
AZN
โ‚น5.221 T 37.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น5.640 T 48.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 51.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.064 T 33.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น4.269 T 12.21%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚น1.507 T-60.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚น29.69 B-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA